These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10821970)

  • 21. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
    Wu CJ; Huang HW; Tao MH
    Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a recombinant vaccine against Japanese encephalitis.
    Kaur R; Vrati S
    J Neurovirol; 2003 Aug; 9(4):421-31. PubMed ID: 12907387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs.
    García-Nicolás O; Ricklin ME; Liniger M; Vielle NJ; Python S; Souque P; Charneau P; Summerfield A
    Viruses; 2017 May; 9(5):. PubMed ID: 28531165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
    Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
    Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
    Halstead SB; Thomas SJ
    Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.
    Wang R; Xie L; Gao N; Fan D; Chen H; Wang P; Zhou H; An J
    Virol Sin; 2019 Jun; 34(3):243-252. PubMed ID: 30911897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese encephalitis vaccines: current vaccines and future prospects.
    Monath TP
    Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Matsuura M; Kojima A; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Clin Vaccine Immunol; 2012 Jan; 19(1):17-22. PubMed ID: 22089248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an effective Japanese encephalitis virus-specific DNA vaccine.
    Wu CJ; Li TL; Huang HW; Tao MH; Chan YL
    Microbes Infect; 2006 Sep; 8(11):2578-86. PubMed ID: 16949850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
    Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
    Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
    Lobigs M; Larena M; Alsharifi M; Lee E; Pavy M
    J Virol; 2009 Mar; 83(6):2436-45. PubMed ID: 19109382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice.
    Nickols B; Tretyakova I; Tibbens A; Klyushnenkova E; Pushko P
    Virology; 2017 Dec; 512():66-73. PubMed ID: 28938099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.